Effect of 2-week postpartum check-ups on screening positive for postpartum depression: a population-based cohort study using instrumental variable estimation in Japan
Family Practice · 2025
DOI: 10.1093/fampra/cmad074 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Family Practice, 2025. Verfasst von Naoko Nakamura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. Hauptthemen laut MEDLINE: Depression, Postpartum, Mass Screening, Postnatal Care. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.
Themen: Depression
Abstract (Originalsprache)
Background
Postpartum depression is experienced by approximately 10% of women and affects the health and development of their children. Although it is recommended that all mothers have the opportunity for early detection and intervention for postpartum depression, it is unclear whether early postpartum check-ups help to reduce postpartum depression.
Objective
The aim of this study was to assess the effect of 2-week postpartum check-ups on screening positive for postpartum depression in Japan.
Methods
This was a population-based cohort study that used the administrative database of Tsuyama, Japan. Participants were women who received postpartum home visits from a public health nurse in Tsuyama during the fiscal years 2017–2019. Data were obtained on participant’s attendance at a 2-week postpartum check-up and their responses on the Edinburgh Postpartum Depression Scale. Owing to the initiation of a publicly funded postpartum check-up programme, participants were pseudo-randomly assigned to receive/not receive a 2-week postpartum check-up. We conducted instrumental variable estimation to assess the causal effects of the check-up on screening positive for postpartum depression.
Results
The characteristics of the 1,382 participants did not differ by fiscal year of childbirth. We found a 6.7% (95% confidence interval 2.2–11.2) reduction in the prevalence of screening positive for postpartum depression as an effect of 2-week postpartum check-ups among women received 1-month postpartum home visits.
Conclusion
The results suggest that 2-week postpartum check-ups are effective in reducing the prevalence of screening positive for postpartum depression among 1-month postpartum women. Despite some limitations, early postpartum care could reduce postpartum depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
- Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
- Health Promotion Division, Tsuyama City Department of Children's Health, Tsuyama, Japan.
ORCID-Profile: Naoko Nakamura, Toshiharu Mitsuhashi, Yasuko Nakashima, Naomi Matsumoto, Takashi Yorifuji
Förderung
- JSPS KAKENHI
Zitieren
APA
Nakamura, N., Mitsuhashi, T., Nakashima, Y., Matsumoto, N., & Yorifuji, T. (2025). Effect of 2-week postpartum check-ups on screening positive for postpartum depression: a population-based cohort study using instrumental variable estimation in Japan. Family Practice. https://doi.org/10.1093/fampra/cmad074
Vancouver
Nakamura N, Mitsuhashi T, Nakashima Y, Matsumoto N, Yorifuji T. Effect of 2-week postpartum check-ups on screening positive for postpartum depression: a population-based cohort study using instrumental variable estimation in Japan. Family Practice. 2025. doi:10.1093/fampra/cmad074
BibTeX
@article{Nakamura2025,
author = {Nakamura, Naoko and Mitsuhashi, Toshiharu and Nakashima, Yasuko and Matsumoto, Naomi and Yorifuji, Takashi},
title = {Effect of 2-week postpartum check-ups on screening positive for postpartum depression: a population-based cohort study using instrumental variable estimation in Japan},
journal = {Family Practice},
year = {2025},
doi = {10.1093/fampra/cmad074}
}
EUVIMED